Safety Profile of Children in an Enclosure Bed

Eileen Sherburne1, Julia A Snethen, Sheryl Kelber

  • 1Author Affiliations: Clinical Nurse Specialist-Spina Bifida, Children's Hospital of Wisconsin, Milwaukee (Ms Sherburne); Associate Professor (Dr Snethen) and Biostatistician (Ms Kelber), College of Nursing, University of Wisconsin.

Insights

Enclosure beds can improve safety for hospitalized children with behavioral challenges. Children with new cognitive impairments experienced more falls and injuries when using these beds.

Area of Science:

  • Pediatric nursing
  • Patient safety
  • Child behavioral health

Background:

  • Behavioral challenges in hospitalized children can compromise safety.
  • Enclosure beds are utilized to prevent injury in this population.
  • Limited research exists on pediatric enclosure bed use.

Purpose of the Study:

  • Examine the use of enclosure beds in pediatric care.
  • Identify children benefiting from enclosure beds.
  • Analyze safety factors associated with enclosure bed implementation.

Main Methods:

  • Retrospective chart review of 208 pediatric enclosure bed encounters.
  • Analyzed demographics, length of stay, and bed use.
  • Examined behavioral medications, restraint use, skin breakdown, and falls.

Main Results:

  • Children were categorized by cognitive function: no impairment, new impairment, congenital impairment.
  • Significant differences in safety variables were observed across groups.
  • Children with new-onset cognitive impairment had higher rates of falls, skin breakdown, and injury.

Conclusions:

  • Enclosure beds are a reasonable intervention for specific pediatric patients requiring enhanced safety.
  • Findings enhance nursing knowledge for managing challenging pediatric populations.
  • Optimizing safe and effective care for hospitalized children with behavioral issues.
Abstract

Related Concept Videos

Attachment01:20

Attachment

Attachment is vital for infant development, as warm social interactions support growth and well-being. In a classic 1958 study by Harry Harlow, the significance of warmth and comfort in forming attachments was examined. Harlow separated newborn monkeys from their mothers and provided two artificial "mothers": one made of cold wire and the other covered in soft cloth. Despite the wire mother offering food, the infant monkeys preferred the comfort of the cloth mother, demonstrating that...
652
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
605
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
645
Piaget's Stage 1 of Cognitive Development01:14

Piaget's Stage 1 of Cognitive Development

The sensorimotor stage, the initial phase of Jean Piaget's theory of cognitive development, spans the first two years of a child's life. During this period, infants actively engage with their surroundings, building cognitive awareness through direct interaction with the world. This interaction is primarily based on sensory perception and motor actions, allowing infants to gradually understand basic physical properties and predict how objects interact within their environment.
Exploration...
2.2K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
411
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306